P. Pillans

发表

DRUG‐ASSOCIATED ALOPECIA

P. Pillans, D. J. Woods, D. Woods, 1995, International journal of dermatology.

Concordance between use of proton pump inhibitors and prescribing guidelines

V. Overland, P. Pillans, P. Kubler, 2000 .

Effects of perhexiline on myocardial deformation in patients with ischaemic left ventricular dysfunction.

T. Marwick, R. Leano, J. Horowitz, 2010, International journal of cardiology.

Polypharmacy among inpatients aged 70 years or older in Australia

I. Scott, N. Peel, Jennifer H. Martin, 2015, The Medical journal of Australia.

Deciding when to stop: towards evidence-based deprescribing of drugs in older populations

I. Scott, Jennifer H. Martin, P. Pillans, 2012, Evidence-Based Medicine.

A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients.

R. Rigby, S. Tett, P. Taylor, 2001, Clinical biochemistry.

The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial

David W. Johnson, D. Nicol, C. Hawley, 2004, Transplantation.

Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.

David W. Johnson, C. Hawley, S. Tett, 2005, British journal of clinical pharmacology.

Use and monitoring of low dose rituximab in myasthenia gravis

P. Mccombe, R. Henderson, P. Pillans, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Tissue Necrosis and Necrotizing Fasciitis After Intramuscular Administration of Diclofenac

P. Pillans, Nanette O'Connor, 1995, The Annals of pharmacotherapy.

Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review

I. Scott, M. Barras, P. Pillans, 2018, Therapeutic advances in drug safety.

Off‐label use of recombinant factor VIIa in two tertiary hospitals in Queensland

P. Pillans, P. Kubler, D. McLeod, 2013, ANZ journal of surgery.

Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipient.

David W. Johnson, P. Taylor, P. Pillans, 2004, Therapeutic drug monitoring.

Evaluation of Limited Sampling Strategies for Estimation of 12-Hour Mycophenolic Acid Area Under the Plasma Concentration–Time Curve in Adult Renal Transplant Patients

S. Tett, P. Taylor, P. Pillans, 2000, Therapeutic drug monitoring.

Quantification of free mycophenolic acid by high-performance liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry.

S. Tett, P. Taylor, P. Pillans, 2000, Journal of chromatography. B, Biomedical sciences and applications.

The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients.

P. Taylor, P. Pillans, P. Salm, 2000, Clinical therapeutics.

Evaluation of dosage adjustment in patients with renal impairment

P. Pillans, J. Sturtevant, P. Pillans, 2003, Internal medicine journal.

Australian Reports of Bleeding Complications Associated with Antithrombotic Drug Combinations

P. Pillans, R. Ghiculescu, 2008 .

DABIGATRAN MAY NOT BE AN EFFECTIVE ANTICOAGULANT FOR HAEMODIALYSIS

P. Pillans, D. Mudge, J. Sturtevant, 2010, Nephrology.

Phosphate binders in patients with chronic kidney disease.

Kenneth K. L. Au, David W. Johnson, P. Pillans, 2017, Australian prescriber.

National Centre for Adverse Reactions Monitoring report for the period 1 July, 1994 to 3 June, 1996.

P. Pillans, 1997, The New Zealand medical journal.

Effect of Atorvastatin on Cyclosporine Pharmacokinetics in Liver Transplant Recipients

P. Taylor, P. Pillans, P. Kubler, 2004, The Annals of pharmacotherapy.

Drug associated hepatic reactions in New Zealand: 21 years experience.

P. Pillans, PI Pillans, P. Pillans, 1996, The New Zealand medical journal.

The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs.

P. Taylor, P. Pillans, Chun-Hui Tai, 2011, Clinical biochemistry.

The Measurement of Nicotine in Human Plasma by High-Performance Liquid Chromatography-Electrospray-Tandem Mass Spectrometry

P. Taylor, P. Pillans, C. Mitchell, 2004, Therapeutic drug monitoring.

A rapid HPLC-mass spectrometry cyclosporin method suitable for current monitoring practices.

P. Taylor, P. Pillans, P. Salm, 2005, Clinical biochemistry.

Evaluation of 3 internal standards for the measurement of cyclosporin by HPLC-mass spectrometry.

D. Cooper, M. Morris, P. Taylor, 2005, Clinical chemistry.

Drug usage evaluation of antimicrobial therapy for community-acquired pneumonia

P. Pillans, J. M. Radford, D. Looke, 1999 .

Free Mycophenolic Acid Should Be Monitored in Renal Transplant Recipients with Hypoalbuminemia

David W. Johnson, S. Tett, P. Taylor, 2004, Therapeutic drug monitoring.

A HPLC-mass spectrometric method suitable for the therapeutic drug monitoring of everolimus.

P. Taylor, P. Pillans, Kendon S. Graham, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Hypertension with moclobemide

D. Coulter, P. Pillans, 1995, The Lancet.

HYPONATRAEMIA AND CONFUSION IN A PATIENT TAKING KETOCONAZOLE

P. Pillans, P. Cowan, D. Whitelaw, 1985, The Lancet.

Stability of sirolimus (rapamycin) in whole blood.

P. Taylor, P. Pillans, P. Salm, 2000, Therapeutic drug monitoring.

Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients.

P. Taylor, P. Pillans, P. Salm, 2000, Clinical biochemistry.

Measurement of free drug and clinical end-point by high-performance liquid chromatography-mass spectrometry: Applications and implications for pharmacokinetic and pharmacodynamic studies

S. Tett, P. Taylor, P. Pillans, 2003 .

Audit of Ticarcillan/Clavulanate Usage in a Large Teaching Hospital

P. Pillans, D. Looke, J. Sturtevant, 2006 .

Treatment of tuberculosis in patients with pre-existing liver disease or following hepatotoxic drug reactions.

P. Pillans, P. Willcox, S. Robson, 1993, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Fluoxetine and extrapyramidal side effects.

D. Coulter, P. Pillans, David M. Coulter, 1995, The American journal of psychiatry.

Death following allopurinol hypersensitivity syndrome.

H. C. Hanger, P. Pillans, 1994, The New Zealand medical journal.

Adverse reactions associated with nefopam.

P. Pillans, D. J. Woods, D. Woods, 1995, The New Zealand medical journal.

Increasing relevance of pharmacogenetics of drug metabolism in clinical practice

P. Pillans, 2001, Internal medicine journal.

Vitamin A effects on fetal mouse cephalic acetylcholinesterase and choline acetyltransferase

P. Pillans, P. Folb, P. Folb, 1988, Archives of environmental contamination and toxicology.

Rare cause of dyspnoea

P. Pillans, R. Ghiculescu, 2009, Internal medicine journal.

Angiooedema and urticaria with angiotensin converting enzyme inhibitors

D. Coulter, P. Pillans, P. Black, 1996, European Journal of Clinical Pharmacology.

Heparin‐induced thrombocytopenia: recent experience in a large teaching hospital

P. Pillans, H. Gibbs, J. Sturtevant, 2006, Internal medicine journal.

A detection scheme for paraquat poisoning: validation and a five-year experience in Australia.

P. Taylor, P. Pillans, P. Salm, 2001, Journal of analytical toxicology.

Prescribing in the oldest old inpatients: a retrospective analysis of patients referred for specialist geriatric consultation

I. Scott, N. Peel, P. Pillans, 2017, Internal medicine journal.

How prepared are medical graduates to begin prescribing?

P. Pillans, 2009, Internal medicine journal.

Vaccine adverse events reported in New Zealand 1990-5.

P. Pillans, O. Mansoor, P. Pillans, 1997, The New Zealand medical journal.

Off‐label use of rituximab in a tertiary Queensland hospital

P. Pillans, J. Sturtevant, B. Horn, 2010, Internal medicine journal.

Neurotoxicity in chronic lithium poisoning

K. Isoardi, P. Pillans, P. M. Hlaing, 2020, Internal medicine journal.

P-glycoprotein and its role in drug-drug interactions

P. Pillans, A. Finch, 2014 .

A clinical audit of high‐cost and off‐label drug use in dermatology

H. Soyer, P. Pillans, E. McMeniman, 2017, The Australasian journal of dermatology.

Simultaneous Quantification of Tacrolimus and Sirolimus, in Human Blood, by High-Performance Liquid Chromatography–Tandem Mass Spectrometry

P. Taylor, P. Pillans, P. Salm, 2000, Therapeutic drug monitoring.

Therapeutic drug monitoring of tacrolimus by liquid chromatography-tandem mass spectrometry: is it truly a routine test?

P. Taylor, P. Pillans, Chun-Hui Tai, 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

The effects of in vivo administration of teratogenic doses of vitamin A during the preimplantation period in the mouse.

P. Pillans, S. Ponzi, P. Folb, 1988, Teratology.

Cisapride increases micturition frequency.

P. Pillans, S. Wood, 1994, Journal of clinical gastroenterology.

Pregnancy associated with a combined oral contraceptive and itraconazole.

P. Pillans, M. Sparrow, 1993, The New Zealand medical journal.

Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection.

David W. Johnson, S. Tett, P. Taylor, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Solitary abscess of the spleen. A report of 2 cases.

P. Pillans, M. Moosa, 1985, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Drug Cost Containment at a Large Teaching Hospital

P. Pillans, Ian Conry, Barbara E. Gie, 1992, PharmacoEconomics.

Experience with low‐dose rituximab in off‐label indications at two tertiary hospitals

P. Pillans, P. Kubler, P. Donovan, 2013, Internal medicine journal.

Using N-of-1 Trials to Improve Patient Management and Save Costs

Paul Glasziou, Jane Nikles, Philip J. Schluter, 2010, Journal of General Internal Medicine.

Herbal medicine and toxic hepatitis.

P. Pillans, R. Massey, M. N. Eade, 1994, The New Zealand medical journal.

Quality of medication ordering at a large teaching hospital

I. Coombes, P. Pillans, J. M. Radford, 2001 .

Quantification and stability of everolimus (SDZ RAD) in human blood by high-performance liquid chromatography-electrospray tandem mass spectrometry.

P. Taylor, P. Pillans, P. Salm, 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Cyclophosphamide effects on fetal mouse cephalic acetylcholinesterase

P. Pillans, P. Folb, B. A. Stephenson, 2004, Archives of Toxicology.

Cyclophosphamide induced DNA strand breaks in mouse embryo cephalic tissue in vivo.

M. Parker, P. Pillans, S. Ponzi, 1989, Carcinogenesis.

Accurate estimation of mycophenolic acid AUC.

S. Tett, P. Taylor, P. Pillans, 2001, Therapeutic drug monitoring.

Association of pre-transplant statin use with delayed graft function in kidney transplant recipients

David W. Johnson, J. Reiling, P. Pillans, 2012, BMC Nephrology.

A medication review and deprescribing method for hospitalised older patients receiving multiple medications

I. Scott, P. Pillans, M. Mckean, 2016, Internal medicine journal.

Captopril-associated agranulocytosis

P. Pillans, A. Koopowitz, 1991 .

Fluoxetine and hyponatraemia--a potential hazard in the elderly.

D. Coulter, P. Pillans, 1994, The New Zealand medical journal.

Interaction of phenytoin and fluoxetine.

D. Coulter, P. Pillans, D. Woods, 1994, The New Zealand medical journal.

Adherence to guideline‐based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital

P. Pillans, M. Mckean, M. Fanning, 2014, Internal medicine journal.

Toxicity of herbal products.

P. Pillans, P. Pillans, 1995, The New Zealand medical journal.

Measurement of urinary oxypurinol by high performance liquid chromatography-tandem mass spectrometry.

R. Day, K. Williams, P. Taylor, 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

A survey of allopurinol dosage prescribing.

P. Pillans, A. McClintock, A. J. Egan, 1995, The New Zealand medical journal.

Outcomes in patients with gram-negative sepsis treated with gentamicin

P. Pillans, R. Sheehy, P. Donovan, 2012, Therapeutic Advances in Drug Safety.

Self‐poisoning by older Australians: a cohort study

P. Pillans, G. Isbister, C. Page, 2017, The Medical journal of Australia.

Angiotensin-converting enzyme inhibitors and psoriasis.

D. Coulter, P. Pillans, 1993, The New Zealand medical journal.

Evaluation of cyclooxygenase 2 inhibitor use in patients admitted to a large teaching hospital

P. Pillans, J. M. Radford, P. Landsberg, 2003, Internal medicine journal.

au Nof-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain

J. Nikles, C. Mar, P. Schluter, 2017 .

Recrudescence of Plasmodium falciparum malaria contracted in Lombok, Indonesia after quinine/doxycycline and mefloquine: case report.

P. Pillans, K. N. Tish, 1997, The New Zealand medical journal.

Integrating a pharmacist into the perioperative setting.

M. Barras, C. Snoswell, P. Pillans, 2020, Australian health review : a publication of the Australian Hospital Association.

Overprescribing: have we made any progress?

M. Roberts, P. Pillans, 1999, Australian and New Zealand journal of medicine.

Roxithromycin and Hepatitis

P. Pillans, T. Maling, 1993 .

Clinical perspectives in drug safety and adverse drug reactions

P. Pillans, 2008, Expert review of clinical pharmacology.

Chickenpox pneumonia. A case report.

P. Pillans, 1983, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Leflunomide-Associated Pancytopenia With or Without Methotrexate

P. Pillans, D. Sanders, Jonathan Chan, 2004, The Annals of pharmacotherapy.

N-of-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain.

Philip J Schluter, C. Nikles, C. Del Mar, 2009, Pain medicine.

Experimental and clinical pharmacology Immunosuppressants - mechanisms of action and monitoring

P. Pillans, 2006 .

A survey of inpatient antibiotic use in a teaching hospital.

S. Oliver, P. Pillans, B. Till, 1991, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Severe acute liver injury associated with lumiracoxib

P. Pillans, G. Macdonald, R. Wong, 2012, Journal of gastroenterology and hepatology.

The influence of atorvastatin on cyclosporin method for the measurement of cyclosporin pharmacokinetics in stable liver transplant recipients

P. Taylor, P. Pillans, P. Kubler, 2003 .

Concordance between clopidogrel use and prescribing guidelines

P. Pillans, M. Frogley, P. Kubler, 2004, Internal medicine journal.

Pharmacovigilance in Australia and New Zealand: towards 2000

D. Coulter, P. Pillans, T. Mathew, 1999, The Medical journal of Australia.

Experience with Drotrecogin in Two Australian Hospitals

P. Pillans, D. Cook, P. Kubler, 2006 .

Acute polyarthritis associated with azathioprine for interstitial lung disease.

P. Pillans, G. Ainslie, E. Bateman, 1995, Respiratory medicine.

Simultaneous determination of tacrolimus and sirolimus by liquid chromatography tandem mass spectrometry (9HPLC0MS/MS)

P. Taylor, P. Pillans, P. Salm, 1999 .

Possible Interaction between Cisapride and Digoxin

P. Pillans, P. Kubler, Peter I Pillans, 2001, The Annals of pharmacotherapy.

Analytical performance of microparticle enzyme immunoassay and HPLC-tandem mass spectrometry in the determination of sirolimus in whole blood.

P. Taylor, P. Pillans, P. Salm, 1999, Clinical Chemistry.

Anticoagulation during pregnancy.

P. Pillans, E. Coetzee, 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Use and monitoring of low dose rituximab in myasthenia gravis

P. Mccombe, R. Henderson, P. Pillans, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Phosphate binders in patients with chronic kidney disease.

David W. Johnson, P. Pillans, D. Mudge, 2017, Australian prescriber.

Improving Concordance Between Use of Proton Pump Inhibitors and Prescribing Guidelines

P. Pillans, J. M. Radford, Fraser Mackenzie, 2002, Medical Journal of Australia.